ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Sanofi announces myeloma drug meets primary endpoint
February 19, 2019French pharma giant Sanofi has unveiled that its multiple myeloma drug isatuximab has met its primary endpoint of prolonged progression-free survival in a Phase III trial..... -
Bristol-Myers, AbbVie net FDA 'breakthrough' for myeloma drug Empliciti
August 27, 2018The myeloma drug Empliciti is currently approved alongside Revlimid and dexamethasone for patients who have already received anywhere from one to three prior treatments.
Pharma Sources Insight January 2025
